Clinical Trial: AKI and Delirium Risk Prediction and Cost Burden Study

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866560) titled 'AKI and Delirium Risk Prediction and Cost Burden Study' on Sept. 15.

Brief Summary: The goal of this study is to learn how to better predict two common health problems that can happen during a hospital stay: acute kidney injury (AKI) and delirium. AKI is a sudden decline in kidney function. Delirium is a sudden change in thinking or awareness that can cause confusion. Both conditions can make people stay in the hospital longer and may increase health care costs.

The two main questions this study aims to answer are:

1. How do hospital acquired AKI and delirium affect how long people stay in the hospital and the cost of their care? ...